2017
DOI: 10.1093/cvr/cvx250
|View full text |Cite
|
Sign up to set email alerts
|

Optogenetic termination of atrial fibrillation in mice

Abstract: We provide the first evidence for optogenetic termination of atrial tachyarrhythmia in intact hearts from transgenic as well as wild type mice ex and in vivo. Thus, this report could lay the foundation for the development of implantable devices for pain-free termination of AF.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
66
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 64 publications
(67 citation statements)
references
References 46 publications
1
66
0
Order By: Relevance
“…We expect this technology will be a powerful tool in cardiac research because it allows for mechanistic dissection of the interplay between genotype and phenotype during normal and pathological cardiac physiology, as well as providing therapeutic interventions for cardiac arrhythmias. [ 9,60,61 ] In addition, this multifunctional platform could be easily translated to neuroscience applications, such as miniaturized implantable optoelectronic neural interfaces for bidirectional monitoring and modulating neural activity, [ 62,63 ] brain–machine interfaces, [ 64,65 ] closed‐loop therapeutic deep brain stimulation, [ 66,67 ] etc. Ongoing and future research will focus on developing scale‐up fabrication strategies, [ 68 ] high‐performance nanogrid electrodes with subcellular resolution to enable recordings from single cells, and large‐scale multisite implantable arrays for chronic in vivo cardiac, neural, and skeletal muscle optical interventions with electrophysiological recordings.…”
Section: Resultsmentioning
confidence: 99%
“…We expect this technology will be a powerful tool in cardiac research because it allows for mechanistic dissection of the interplay between genotype and phenotype during normal and pathological cardiac physiology, as well as providing therapeutic interventions for cardiac arrhythmias. [ 9,60,61 ] In addition, this multifunctional platform could be easily translated to neuroscience applications, such as miniaturized implantable optoelectronic neural interfaces for bidirectional monitoring and modulating neural activity, [ 62,63 ] brain–machine interfaces, [ 64,65 ] closed‐loop therapeutic deep brain stimulation, [ 66,67 ] etc. Ongoing and future research will focus on developing scale‐up fabrication strategies, [ 68 ] high‐performance nanogrid electrodes with subcellular resolution to enable recordings from single cells, and large‐scale multisite implantable arrays for chronic in vivo cardiac, neural, and skeletal muscle optical interventions with electrophysiological recordings.…”
Section: Resultsmentioning
confidence: 99%
“…The AADwc method can provide an efficient and optimal strategy in the design of control schemes for the removal of any type of anchored reentry in the heart, as it clearly demonstrates that real-time spatiotemporal control of scroll waves can be achieved, even with sub-transmural illumination of cardiac tissue. Although in practice, the application of optogenetics to cardiology, is, in itself, a debatable topic, recent advances in cardiac optogenetics [46][47][48][49][50][51][52] promise a brighter future. One of the biggest challenges faced by existing scroll wave control methods is that the control pulses (electrical or optical), can only be applied to the surface of the heart.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have been also carried out on the hearts of mice, especially in the field of atrial fibrillation (AF). The idea was to modulate the heart rhythm, using light radiation on genetically modified ChR2 proteins [37]. These proteins can activate or inhibit the potassium (K) channel, thus shortening the atrial refractoriness and improving the atrial conduction.…”
Section: Applications In Heart Failurementioning
confidence: 99%